Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Physical Examination × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

CNS 4 Head & Neck 3 Breast 3 Tumor-Agnostic 1 Thoracic 1 Other hematologic neoplasm 1 Other 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Skin Cancer Face 1

Interventions

pembrolizumab 300 Nivolumab 266 Ipilimumab 238 Cyclophosphamide 176 aldesleukin 135 Interleukin-2 97 fludarabine phosphate 93 trametinib 79 fludarabine 76 Dacarbazine 73 Temozolomide 70 dabrafenib 69 Radiotherapy 69 Biopsy 66 Vemurafenib 64 Radiosurgery 48 Imiquimod 48 Bevacizumab 47 Magnetic Resonance Spectroscopy 46 Blood Specimen Collection 45 sargramostim 43 Specimen Handling 43 Aminolevulinic Acid 43 3-ingenyl angelate 42 Peripheral Blood Stem Cell Transplantation 41 Cisplatin 41 Paclitaxel 40 atezolizumab 39 Carboplatin 39 cemiplimab 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03382704 2026-01-16

Vellus Hair Loss as a Marker for Peri-ocular Malignancy

NHS Lothian

Skin Cancer Face

Data powered by HemOnc (CC BY 4.0) Colophon ⚡